Clinical Trials Directory

Trials / Terminated

TerminatedNCT05698563

Intermetatarsal Bursitis in Patients With Rheumatoid Arthritis

Clinical Implication of Intermetatarsal Bursitis in Patients With Rheumatoid Arthritis

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to investigate the incidence and clinical implications of intermetatarsal bursitis (IMB) in patients with rheumatoid arthritis (RA). The hypothesis is that IMB is a cause of pain in patients with RA.

Detailed description

Within the recent years more research have focused on IMB in patients with rheumatologic disorders. There is emerging evidence that IMB is an inflammatory alteration in line with synovitis in patients with RA, and presence of IMB have been linked to the early stages of RA, especially due to the focus of the published literature. The clinical implications of the presence of IMB for the patients are yet to be understood. Limited studies have linked the occurrence of IMB to foot impairment, but no studies have been conducted investigating the direct association between forefoot pain and the presence/absence of IMB.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMagnetic resonance imagingMRI scan with contrast of the foot or feet
DIAGNOSTIC_TESTUltrasoundUltrasound scan of the feet
DRUGCorticosteroid injectionAdministered ultrasound guided to patients with intermetatarsal bursitis
OTHERClinical foot evaluationAn examination of the feet
OTHERPicture of the feetTo evaluate the presence of V-sign/spreading toes

Timeline

Start date
2023-01-18
Primary completion
2023-02-14
Completion
2024-12-12
First posted
2023-01-26
Last updated
2025-09-22

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05698563. Inclusion in this directory is not an endorsement.